GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
6.7k
c/tirzepatide·posted 2 years ago by u/copay_card_cc

[PSA] Mounjaro is not what most of this community thinks it is

Results Sourced ×4 Slow Clap ×3 Receipts ×2

Week 70 update. 46kg down from the start, early fullness basically gone since about week 15.

Things that worked: consistency, protein at breakfast, walking more than I want to. Things that did not: everything I bought on the internet to help with early fullness.

The part that surprised me is how much of this is admin. Ordering, storing, logging, remembering. Nobody mentions that the hard bit is not the drug, it is the routine.

Happy to answer anything. Please do not ask me what dose you should be on.

8,509 up / 1,794 down83% upvoted38 commentsid 15ec3s14 Jun 2024

38 comments

30 in this archive, depth 5

best — the order this archive was captured in

u/gentle_correctionnice about it1.1k points·2 years ago·edited

Half-life is about 168 hours, so steady state lands around week 16–5. Practical consequence: what you feel in week 1 is not what that dose does.

replysharereportpermalink
u/dario_stanescu1k points·2 years ago

Is that on Mounjaro pens or research tirzepatide?

replysharereportpermalink
u/incretin_ivypharmacology528 points·2 years ago

SURMOUNT data is messier than STEP data but the weight loss is there

replysharereportpermalink
u/tove_vasquez359 points·2 years ago

Zepbound and Mounjaro are literally the same drug, the name is the only difference

replysharereportpermalink
u/copay_card_ccOP181 points·2 years ago

Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.

replysharereportpermalink
u/copay_card_ccOP120 points·2 years ago

Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.

Yes, exactly this, and it is the bit that took me 42 weeks to accept.

replysharereportpermalink
u/slow_logbook_ftw96 points·2 years ago

Zepbound and Mounjaro are literally the same drug, the name is the only difference

replysharereportpermalink
u/coring_the_stopper487 points·2 years ago
search before post, but also, welcome
replysharereportpermalink
u/b12_baseline251 points·2 years ago

I am going to push back on this slightly.

replysharereportpermalink
load more comments (1) →
u/halima_boateng288 points·2 years ago

Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.

replysharereportpermalink
u/tidy_vialdrawer_pls414 points·2 years ago

the 15mg is the top of the pen, not the required dose

replysharereportpermalink
[removed]117 points·2 years ago

[removed by moderator]

replysharereportpermalink
u/kaia_wojcik95 points·2 years ago

Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.

replysharereportpermalink
u/laila_wikstrom47 points·2 years ago

SURMOUNT data is messier than STEP data but the weight loss is there

replysharereportpermalink
u/tarek_kirchner13 points·2 years ago

Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.

replysharereportpermalink
load more comments (1) →
u/spain_receta224 points·2 years ago

the dual agonism hits different and that is why people describe it differently

replysharereportpermalink
u/nabila_ogunleye176 points·2 years ago·edited

Week 20 on Mounjaro and 11kg down. The appetite reduction feels different from sema in ways I do not have words for yet.

replysharereportpermalink
u/titration_marshalMOD151 points·2 years ago

Flair changed to match the content. Read the sidebar before posting next time and we are square.

replysharereportpermalink
u/swirl_dont_shakereconstitution33 points·2 years ago

the GIP side does different things than the GLP-1 side, that is the point

replysharereportpermalink
u/britt_okwuosa21 points·2 years ago

the GIP side does different things than the GLP-1 side, that is the point

Yes, exactly this, and it is the bit that took me 32 weeks to accept.

replysharereportpermalink
u/tove_vasquez10 points·2 years ago·edited

do not crack the pen, we have been over this

replysharereportpermalink
u/rania_diallo71 points·2 years ago

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

replysharereportpermalink
u/sten_bhattacharya-22 points·2 years ago

This matches the trial data. SURMOUNT-1 was 99.2% body weight at 24 weeks.

replysharereportpermalink
u/dario_stanescu1 point·2 years ago·edited

stalled on sema, tried tirz, and the curves were actually different shapes

replysharereportpermalink
u/adnan_nascimento1 point·2 years ago

the early fullness from tirz is different, not necessarily worse

replysharereportpermalink
u/copay_card_ccOP1 point·2 years ago

My ApoB moved faster on tirz than on sema at the same timepoint, which matches what people report.

replysharereportpermalink
u/gentle_correctionnice about it1 point·2 years ago

What was the trial arm you are quoting from? SURMOUNT-1, -2, -3 are all different.

replysharereportpermalink
u/fatima_wojcik1 point·2 years ago·edited

the GIP side does different things than the GLP-1 side, that is the point

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.